Order Article Reprints

Rivero Berti I, Gambaro RC, Limeres MJ, Huck-Iriart C, Svensson M, Fraude-El Ghazi S, Pretsch L, Si S, Lieberwirth I, Landfester K, et al. Encapsulation of Dexamethasone into mRNA–Lipid Nanoparticles Is a Promising Approach for the Development of Liver-Targeted Anti-Inflammatory Therapies. International Journal of Molecular Sciences. 2024; 25(20):11254. https://doi.org/10.3390/ijms252011254

Rivero Berti, Ignacio, Rocío Celeste Gambaro, María José Limeres, Cristián Huck-Iriart, Malin Svensson, Silvia Fraude-El Ghazi, Leah Pretsch, Shutian Si, Ingo Lieberwirth, Katharina Landfester, and et al. 2024. "Encapsulation of Dexamethasone into mRNA–Lipid Nanoparticles Is a Promising Approach for the Development of Liver-Targeted Anti-Inflammatory Therapies" International Journal of Molecular Sciences 25, no. 20: 11254. https://doi.org/10.3390/ijms252011254

Rivero Berti, I., Gambaro, R. C., Limeres, M. J., Huck-Iriart, C., Svensson, M., Fraude-El Ghazi, S., Pretsch, L., Si, S., Lieberwirth, I., Landfester, K., Cacicedo, M. L., Islan, G. A., & Gehring, S. (2024). Encapsulation of Dexamethasone into mRNA–Lipid Nanoparticles Is a Promising Approach for the Development of Liver-Targeted Anti-Inflammatory Therapies. International Journal of Molecular Sciences, 25(20), 11254. https://doi.org/10.3390/ijms252011254